Calcimimetics with potent and selective activity on the parathyroid calcium receptor
Open Access
- 31 March 1998
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 95 (7) , 4040-4045
Abstract
Parathyroid hormone (PTH) secretion is regulated by a cell surface Ca 2+ receptor that detects small changes in the level of plasma Ca 2+ . Because this G protein-coupled receptor conceivably provides a distinct molecular target for drugs useful in treating bone and mineral-related disorders, we sought to design small organic molecules that act on the Ca 2+ receptor. We discovered that certain phenylalkylamine compounds, typified by NPS R-568 and its deschloro derivative NPS R-467, increased the concentration of cytoplasmic Ca 2+ ([Ca 2+ ] i ) in bovine parathyroid cells and inhibited PTH secretion at nanomolar concentrations. These effects were stereoselective and the R enantiomers were 10- to 100-fold more potent than the S enantiomers. NPS R-568 potentiated the effects of extracellular Ca 2+ on [Ca 2+ ] i and PTH secretion but was without effect in the absence of extracellular Ca 2+ . Both compounds shifted the concentration–response curves for extracellular Ca 2+ to the left. Presumably, these compounds act as positive allosteric modulators to increase the sensitivity of the Ca 2+ receptor to activation by extracellular Ca 2+ . Both NPS R-467 and NPS R-568 increased [Ca 2+ ] i in HEK 293 cells expressing the human parathyroid Ca 2+ receptor but were without effect in wild-type HEK 293 cells. Neither compound affected the cytoplasmic Ca 2+ responses elicited by several other G protein-coupled receptors in HEK 293 cells or in bovine parathyroid cells. Significantly, these compounds did not affect responses elicited by the homologous metabotropic glutamate receptors, mGluR1a, mGluR2, or mGluR8. These compounds therefore act selectively on the Ca 2+ receptor. Compounds that mimic or potentiate the effects of extracellular Ca 2+ at the Ca 2+ receptor are termed calcimimetics. The discovery of calcimimetic compounds with potent and selective activity enables a pharmacological approach to regulating plasma levels of PTH. Calcimimetic compounds could conceivably provide a specific medical therapy for primary hyperparathyroidism.Keywords
This publication has 18 references indexed in Scilit:
- Short-Term Inhibition of Parathyroid Hormone Secretion by a Calcium-Receptor Agonist in Patients with Primary HyperparathyroidismNew England Journal of Medicine, 1997
- Metabotropic glutamate receptors: potential drug targetsDrug Discovery Today, 1996
- Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroidNature, 1993
- Polyarginine, polylysine, and protamine mimic the effects of high extracellular calcium concentrations on dispersed bovine parathyroid cellsJournal of Bone and Mineral Research, 1991
- Neomycin Mimics the Effects of High Extracellular Calcium Concentrations on Parathyroid Function in Dispersed Bovine Parathyroid Cells*Endocrinology, 1991
- A Comparison of the Effects of Divalent and Trivalent Cations on Parathyroid Hormone Release, 3′,5′-Cyclic-Adenosine Monophosphate Accumulation, and the Levels of Inositol Phosphates in Bovine Parathyroid CellsEndocrinology, 1990
- Divalent Cations Suppress 3′,5′-Adenosine Monophosphate Accumulation by Stimulating a Pertussis Toxin-Sensitive Guanine Nucleotide-Binding Protein in Cultured Bovine Parathyroid Cells*Endocrinology, 1989
- Regulation of hormone secretion and cytosolic Ca2+ by extracellular Ca2+ in parathyroid cells and C-cells: Role of voltage-sensitive Ca2+ channelsArchives of Biochemistry and Biophysics, 1988
- High Calcium and Other Divalent Cations Increase Inositol Trisphosphate in Bovine Parathyroid Cells*Endocrinology, 1988
- Cytosolic Ca2+ and the regulation of secretion in parathyroid cellsFEBS Letters, 1986